Evidence map›Paper›PMID 32760749›Full record

ArticleOpen forum infectious diseases2020

Effects of Internet Cognitive-Behavioral Therapy on Depressive Symptoms and Surrogates of Cardiovascular Risk in Human Immunodeficiency Virus: A Pilot, Randomized, Controlled Trial.

Samir K Gupta, James E Slaven, Ziyue Liu, Brittanny M Polanka, Matthew S Freiberg, Jesse C Stewart

Erratum issued Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Open forum infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT07226128 (A Randomized, Controlled Trial Assessing the Effects of Cognitive Behavioral Therapy to Prevent Worsening Insulin Resistance in Depressed, Virologically-Suppressed, Antiretroviral-Treated Adults With HIV), which is not on this map. Cited by 4 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 2 pooled it
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07226128 narecruitingnot on this mapstarted 2026, after this paper: background citation

A Randomized, Controlled Trial Assessing the Effects of Cognitive Behavioral Therapy to Prevent Worsening Insulin Resistance in Depressed, Virologically-Suppressed, Antiretroviral-Treated Adults With HIV

TypeinterventionalSponsorIndiana UniversityRan2026 to 2029Enrolled150ConditionsHIV, Depression in Adults, Insulin Resistance, Cognitive Behavior TherapyArmsInternet cognitive behavioral therapy (iCBT-D), Active Control (AC)
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 syntheses or guidelines pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Examining Depression as a Risk Factor for Cardiovascular Disease in People with HIV: A Systematic Review.Annals of behavioral medicine : a publication of the Society of Behavioral Medicine · 2023
    Pooled it
  3. Trial
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Samir K GuptaDivision of Infectious Diseases, Indiana University School of Medicine, Indianapolis, Indiana, USA.
James E SlavenDepartment of Biostatistics, Indiana University School of Public Health, Indianapolis, Indiana, USA.
Ziyue LiuDepartment of Biostatistics, Indiana University School of Public Health, Indianapolis, Indiana, USA.
Brittanny M PolankaDepartment of Psychology, Indiana University-Purdue University-Indianapolis (IUPUI), Indianapolis, Indiana, USA.
Matthew S FreibergCardiovascular Medicine Division, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Jesse C StewartDepartment of Psychology, Indiana University-Purdue University-Indianapolis (IUPUI), Indianapolis, Indiana, USA.
Indiana University – Purdue University Indianapolis · USIndiana University School of MedicineVanderbilt University Medical Center · US

Funding

Quality Assurance and Quality Control Project Management: Improving Submissions and Study Conduct in the Human Subjects Research Prior Approval ProcessUL1TR002529 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI MOE, SHARON M, WIEHE, SARAH ELIZABETH · 2018 to 2022
$27.2M
Translation CoreP30DK097512 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI Carmella Evans-Molina · 2015 to 2026
$17.4M
HIV, Depression, and Cardiovascular RiskR01HL126557 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI FREIBERG, MATTHEW S, GUPTA, SAMIR KUMAR · 2014 to 2017
$2.9M
NCATS NIH HHS UL1 TR002529NHLBI NIH HHS R01 HL126557NIDDK NIH HHS P30 DK097512
6 · The paper itself

Abstract

backgroundDepression is associated with an increased risk of cardiovascular disease in human immunodeficiency virus (HIV). We hypothesized that reducing depressive symptoms would improve HIV-related cardiovascular risk.

methodsWe conducted a single-center, randomized (1:1), controlled, parallel-group, assessor-blinded, pilot trial comparing Beating the Blues US (BtB)-an evidence-based, 8-session, internet cognitive-behavioral therapy for depression-with usual care (UC) in HIV-positive participants receiving virologically suppressive antiretroviral therapy and with Patient Health Questionnaire (PHQ)-9 scores ≥10. The primary endpoint was change in brachial artery flow-mediated dilation (FMD) at 12 weeks. Secondary endpoints were FMD change at 24 weeks and inflammation, coagulation, and metabolic biomarker changes at 12 and 24 weeks.

resultsFifty-four participants were randomized (27 in each arm). Mean reductions in PHQ-9 scores were significantly greater with BtB versus UC at 12 weeks (-5.60 vs -1.52;

conclusionsCompared with UC, internet cognitive-behavioral therapy using BtB resulted in greater improvements in depressive symptoms and monocyte activation markers but did not improve FMD in this pilot trial. These data support performing larger studies to determine the potential salutatory effects of behavioral therapies for depression on HIV-related inflammation.

Indexed as

cognitive-behavioral therapydepressionendothelial functionHIVinflammation

Identifiers

PMID32760749
PMCPMC7393797
OpenAlexW3039936000

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.